Impact of short-term antiretroviral therapy (START) on some fibrinolytic markers in HIV-infected Nigerian adults: preliminary findings from the START study

Zaccheaus A Jeremiah1 Hematology and Blood Transfusion Science Unit, Department of Medical Laboratory Sciences, College of Health Sciences, Niger Delta University, Wilberforce Island, Bayelsa StateCorrespondence[email protected]

Yetunde Obazee2 General Hospital, Maitama District, Abuja, Federal Capital Territory

Godwin R Okogun3 Department of Medical Laboratory Science, Ambrose Ali University, Ekpoma, Edo State, Nigeria

Teddy C Adias4 College of Health Technology, Bayelsa State, Nigeria

Osaro Mgbere5 Houston Department of Health and Human Services, University of Houston, Texas Medical Center, Houston, TX, USA;6 Institute of Community Health, University of Houston, Texas Medical Center, Houston, TX, USA

Ekere J Essien6 Institute of Community Health, University of Houston, Texas Medical Center, Houston, TX, USA

Impact of short-term antiretroviral therapy (START) on some fibrinolytic markers in HIV-infected Nigerian adults: preliminary findings from the START study

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Impact of short-term antiretroviral therapy (START) on some fibrinolytic markers in HIV-infected Nigerian adults: preliminary findings from the START study

Citations (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date